Cargando…

Molecular Biomarker Analyses Using Circulating Tumor Cells

BACKGROUND: Evaluation of cancer biomarkers from blood could significantly enable biomarker assessment by providing a relatively non-invasive source of representative tumor material. Circulating Tumor Cells (CTCs) isolated from blood of metastatic cancer patients hold significant promise in this reg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Punnoose, Elizabeth A., Atwal, Siminder K., Spoerke, Jill M., Savage, Heidi, Pandita, Ajay, Yeh, Ru-Fang, Pirzkall, Andrea, Fine, Bernard M., Amler, Lukas C., Chen, Daniel S., Lackner, Mark R.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935889/ https://www.ncbi.nlm.nih.gov/pubmed/20838621 http://dx.doi.org/10.1371/journal.pone.0012517

Ejemplares similares

Genomic Analysis of Circulating Tumor Cells at the Single-Cell Level
por: Lu, Shan, et al.
Publicado: (2020)

Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
por: Spoerke, Jill M., et al.
Publicado: (2016)

PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients
por: Punnoose, Elizabeth A, et al.
Publicado: (2015)

Acquired PIK3CA amplification causes resistance to selective phosphoinositide 3-kinase inhibitors in breast cancer
por: Huw, L-Y, et al.
Publicado: (2013)

The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant population
por: Wilson, Timothy R, et al.
Publicado: (2016)

High Heregulin Expression Is Associated with Activated HER3 and May Define an Actionable Biomarker in Patients with Squamous Cell Carcinomas of the Head and Neck
por: Shames, David S., et al.
Publicado: (2013)

Correction: High Heregulin Expression Is Associated with Activated HER3 and May Define an Actionable Biomarker in Patients with Squamous Cell Carcinomas of the Head and Neck
por: Shames, David S., et al.
Publicado: (2013)

Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter
por: Qu, X, et al.
Publicado: (2016)

Targeted Biomarker Profiling of Matched Primary and Metastatic Estrogen Receptor Positive Breast Cancers
por: Schleifman, Erica B., et al.
Publicado: (2014)

Circulating DNA as biomarker in breast cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2015)

Circulating nucleic acids as biomarkers in breast cancer
por: Schwarzenbach, Heidi
Publicado: (2013)

Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses
por: van Rees, Jan M., et al.
Publicado: (2023)

Circulating Biomarkers for Predicting Cardiovascular Disease Risk; a Systematic Review and Comprehensive Overview of Meta-Analyses
por: van Holten, Thijs C., et al.
Publicado: (2013)

Circulating tumour cell enumeration, biomarker analyses, and kinetics in patients with colorectal cancer and other GI malignancies
por: Malkawi, Walla, et al.
Publicado: (2023)

The current role of circulating biomarkers in non-muscle invasive bladder cancer
por: Rink, Michael, et al.
Publicado: (2019)

Circulating Biomarkers in Hypertrophic Cardiomyopathy
por: Matthia, Eldon L., et al.
Publicado: (2022)

Biomarkers and the Fontan Circulation
por: Schumacher, Kurt R., et al.
Publicado: (2016)

Circulating Cancer Biomarkers
por: Lokshin, Anna, et al.
Publicado: (2021)

Circulating microRNAs: promising breast cancer biomarkers - authors' response
por: Roth, Carina, et al.
Publicado: (2011)

Mendelian Randomization Analyses of Chronic Immune-Mediated Diseases, Circulating Inflammatory Biomarkers, and Cytokines in Relation to Liver Cancer
por: Yin, Qiushi, et al.
Publicado: (2023)

Systematic Deciphering of Cancer Genome Networks
por: Fendler, Bernard, et al.
Publicado: (2012)

Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA
por: Clark, Travis A., et al.
Publicado: (2018)

Single-cell analyses of circulating tumor cells
por: Chen, Xi-Xi, et al.
Publicado: (2015)

The effect of an antenatal lifestyle intervention in overweight and obese women on circulating cardiometabolic and inflammatory biomarkers: secondary analyses from the LIMIT randomised trial
por: Moran, Lisa J., et al.
Publicado: (2017)

Opportunities and challenges of circulating biomarkers in neuroblastoma
por: Trigg, Ricky M., et al.
Publicado: (2019)

Dysregulated MicroRNA Expression Profiles and Potential Cellular, Circulating and Polymorphic Biomarkers in Non-Hodgkin Lymphoma
por: Bradshaw, Gabrielle, et al.
Publicado: (2016)

Prevalence of Hepatitis B and Hepatitis C in Patients undergoing hemodialysis at a teaching hospital in Uttarakhand
por: Raina, Dimple, et al.
Publicado: (2022)

Circulating Biomarkers in Cardiovascular Disease
por: Ingelsson, Erik
Publicado: (2009)

Circulating Biomarkers in Bladder Cancer
por: Nandagopal, Lakshminarayanan, et al.
Publicado: (2016)

Year of Expanding into Circulating Biomarkers
por: Jia, Shidong, et al.
Publicado: (2015)

Electrochemical Genosensing of Circulating Biomarkers
por: Campuzano, Susana, et al.
Publicado: (2017)

Circulating biomarkers in patients with glioblastoma
por: Müller Bark, Juliana, et al.
Publicado: (2019)

Computational chemoproteomics to understand the role of selected psychoactives in treating mental health indications
por: Fine, Jonathan, et al.
Publicado: (2019)

om92 , a glp-1 enhancer mutation, is an allele of ekl-1
por: Stein, Samantha A., et al.
Publicado: (2022)

Exercise reduces circulating biomarkers of cellular senescence in humans
por: Englund, Davis A., et al.
Publicado: (2021)

Circulating Tumour Cell Biomarkers in Head and Neck Cancer: Current Progress and Future Prospects
por: Payne, Karl, et al.
Publicado: (2019)

Circulating Hybrid Cells Join the Fray of Circulating Cellular Biomarkers
por: Sutton, Thomas L., et al.
Publicado: (2019)

A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types
por: Wagle, Marie-Claire, et al.
Publicado: (2018)

Technical Factors Involved in the Measurement of Circulating MicroRNA Biomarkers for the Detection of Colorectal Neoplasia
por: Yamada, Atsushi, et al.
Publicado: (2014)

Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples
por: Wilson, Timothy R., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e29l5i23qtrt6spcrfqbe7m9tv